Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, January 9, 2023
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
[ Mon, Jan 09th 2023
] - WOPRAI
Sun, January 8, 2023
[ Sun, Jan 08th 2023
] - WOPRAI
[ Sun, Jan 08th 2023
] - WOPRAI
Fri, January 6, 2023
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
[ Fri, Jan 06th 2023
] - WOPRAI
Yasmeen Rahimi Upgraded (ALGS) to Buy and Increased Target to $75 on, Jan 6th, 2023
Yasmeen Rahimi of Piper Sandler, Upgraded "Aligos Therapeutics, Inc." (ALGS) to Buy and Increased Target from $50 to $75 on, Jan 6th, 2023.
Yasmeen has made no other calls on ALGS in the last 4 months.
There is 1 other peer that has a rating on ALGS. Out of the 1 peers that are also analyzing ALGS, all agrees with Yasmeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Roanna Ruiz of "SVB Leerink" Maintained at Hold with Decreased Target to $50 on, Thursday, November 3rd, 2022
